DIABNEXT | DIABNEXT® clinical studies
17263
page-template,page-template-full_width,page-template-full_width-php,page,page-id-17263,ajax_fade,page_not_loaded,,columns-4,qode-theme-ver-10.0,wpb-js-composer js-comp-ver-4.12,vc_responsive
 

DIABNEXT® clinical studies

SMART AUTO-FILL LOGBOOK ON MOBILE IMPROVES DIABETES CARE

DIABNEXT Program is the world’s first diabetes program which provides smart devices and application to monitor insulin, blood glucose and carbs.

 

The use of a diabetes-related smartphone application combined with support from a health care professional can significantly improve glycemic control in adults with type 1 diabetes. 1

 

Timely feedback to providers prescribing medications may improve short-term diabetes outcomes, such as HbA1c levels.2 Health coaching in primary care appears to lead to significant benefits for patients from lower-SES communities with poorly controlled type 2 diabetes.3

Reduce HbA1C level to increase life

Studies have shown that even a 1% reduction in HbA1C level can lead to increased life expectancy by significantly reducing the risks of various diabetes-related complication

Participate in our clinical studies

Current &upcoming Diabnext Clinical Trials in the world

  • Clinical trial in Taiwan
  • Clinical trial in Singapore
  • Clinical trial in India
  • Clinical trial in Germany
  • Clinical trial in Dubai
0
Connecting
Please wait...
Send a message

Sorry, we aren’t online at the moment. Please leave a message

Your name
* Email
* Send me message
Login now

Need more help? Save time by starting your support request online.

Your name
* Email
* Send me message
We're online!
Feedback

Help us help you better! Feel free to leave us any additional feedback.

How do you rate our support?